A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma
Clinical trial NCT06192888 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06192888
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-08
- Primary completion
- 2028-01-08
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.